Vemurafenib in patients with BRAF(V600) mutation-positive melanoma with symptomatic brain metastases: final results of an open-label pilot study (Q34658082)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Vemurafenib in patients with BRAF(V600) mutation-positive melanoma with symptomatic brain metastases: final results of an open-label pilot study
scientific article

    Statements

    Vemurafenib in patients with BRAF(V600) mutation-positive melanoma with symptomatic brain metastases: final results of an open-label pilot study (English)
    Simone M Goldinger
    Christian P Turtschi
    Nina B Eggmann
    Olivier Michielin
    Lada Mitchell
    Luisa Veronese
    Paul René Hilfiker
    Lea Felderer
    Jeannine D Rinderknecht
    29 November 2013

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit